Autologous hematopoietic stem cell transplantation in tandem with anti-CD30 CAR T-cell infusion in relapsed/refractory CD30+ lymphoma.

被引：0
|
作者：
Yang, Xiuxiu [1 ]
Zhang, Peiling [1 ]
Cao, Yang [1 ]
Wang, Jue [1 ]
Zhou, Mi [1 ]
Li, Chunrui [1 ]
Zhou, Jianfeng [1 ]
Huang, Liang [1 ]
机构：
[1] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
基金：
中国国家自然科学基金;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7532
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Pathobiology of CD30+ cutaneous T-cell lymphomas
    Kadin, ME
    JOURNAL OF CUTANEOUS PATHOLOGY, 2006, 33 : 10 - 17
  • [22] FingolimodPrimary anaplastic CD30+ cutaneous T-cell lymphoma: case report
    Reactions Weekly, 2018, 1709 (1) : 102 - 102
  • [23] Autologous stem cell transplantation with positive selection of CD34 cells for angioimmunoblastic T-cell lymphoma.
    de Paz, R
    Canales, MA
    Arrieta, R
    Cobo, T
    Hernandez, D
    Hernandez-Navarro, F
    BLOOD, 2003, 102 (11) : 486B - 486B
  • [24] Allogenic and autologous anti-CD7 CAR-T cell therapies in relapsed or refractory T-cell malignancies
    Zhang, Yinqiang
    Li, Chenggong
    Du, Mengyi
    Jiang, Huiwen
    Luo, Wenjing
    Tang, Lu
    Kang, Yun
    Xu, Jia
    Wu, Zhuolin
    Wang, Xindi
    Huang, Zhongpei
    Zhang, Yanlei
    Wu, Di
    Chang, Alex H. H.
    Hu, Yu
    Mei, Heng
    BLOOD CANCER JOURNAL, 2023, 13 (01)
  • [25] Phase 1 Clinical Trial of Memory-Enriched Academic HSP-CAR30 for the Treatment of Relapsed/Refractory Hodgkin Lymphoma and CD30+ T-Cell Lymphoma: Clinical and Biological Studies
    Caballero Gonzalez, Ana Carolina Carolina
    Escriba-Garcia, Laura
    Montserrat, Rosanna
    Escudero-Lopez, Eva
    Pujol-Fernandez, Paula
    Ujaldon-Miro, Cristina
    Garcia-Cadenas, Irene
    Esquirol, Albert
    Martino, Rodrigo
    Sierra, Jorge
    Alvarez-Fernandez, Carmen
    Briones, Javier
    BLOOD, 2022, 140
  • [26] Allogenic and autologous anti-CD7 CAR-T cell therapies in relapsed or refractory T-cell malignancies
    Yinqiang Zhang
    Chenggong Li
    Mengyi Du
    Huiwen Jiang
    Wenjing Luo
    Lu Tang
    Yun Kang
    Jia Xu
    Zhuolin Wu
    Xindi Wang
    Zhongpei Huang
    Yanlei Zhang
    Di Wu
    Alex H. Chang
    Yu Hu
    Heng Mei
    Blood Cancer Journal, 13
  • [27] Anaplastic large T cell CD30+ lymphoma (ALCL)
    De Pasquale, R
    Torrisi, L
    Gangemi, P
    Micali, G
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 123 (05) : A96 - A96
  • [28] SGN-30 (anti-CD30 monoclonal antibody) is active and well tolerated in patients with refractory or recurrent systemic anaplastic large cell lymphoma.
    Forero-Torres, A
    Bernstein, S
    Gopal, A
    Foss, F
    Leonard, J
    Rosenblatt, J
    Bartlett, N
    Younes, A
    Fisher, D
    Cheson, B
    Carabasi, M
    Bociek, G
    Hart, B
    McDonald, M
    BLOOD, 2004, 104 (11) : 721A - 722A
  • [29] INTRAEPIDERMAL IGA PUSTULOSIS PRECEDING A CD30+ ANAPLASTIC LARGE T-CELL LYMPHOMA
    GUGGISBERG, D
    HOHL, D
    DERMATOLOGY, 1995, 191 (04) : 352 - 354
  • [30] CiclosporinPrimary cutaneous CD30+ anaplastic large T-cell lymphoma: case report
    Reactions Weekly, 2021, 1870 (1) : 87 - 87
12345